CRIS Current Research Information System

CAMPIERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.772
AS - Asia 8.282
EU - Europa 6.050
AF - Africa 537
SA - Sud America 519
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.584
VN - Vietnam 2.605
SG - Singapore 2.157
CN - Cina 1.770
GB - Regno Unito 1.344
IT - Italia 943
SE - Svezia 828
DE - Germania 758
HK - Hong Kong 595
FR - Francia 437
BR - Brasile 383
RU - Federazione Russa 351
IN - India 345
UA - Ucraina 302
IE - Irlanda 294
JP - Giappone 164
NL - Olanda 154
TG - Togo 139
FI - Finlandia 137
CI - Costa d'Avorio 129
ZA - Sudafrica 117
KR - Corea 110
BG - Bulgaria 100
CH - Svizzera 97
JO - Giordania 93
CA - Canada 86
EE - Estonia 84
SC - Seychelles 83
BD - Bangladesh 81
BE - Belgio 66
PH - Filippine 63
AR - Argentina 60
TH - Thailandia 40
IQ - Iraq 37
HN - Honduras 36
ID - Indonesia 33
PL - Polonia 32
MX - Messico 30
TW - Taiwan 30
ES - Italia 26
NG - Nigeria 26
TR - Turchia 24
GR - Grecia 21
IR - Iran 21
PK - Pakistan 20
UZ - Uzbekistan 20
AU - Australia 18
CL - Cile 18
SA - Arabia Saudita 18
EC - Ecuador 16
BZ - Belize 15
AT - Austria 12
CZ - Repubblica Ceca 12
CO - Colombia 11
MY - Malesia 11
PY - Paraguay 11
HR - Croazia 10
VE - Venezuela 10
RO - Romania 9
EG - Egitto 8
ET - Etiopia 8
JM - Giamaica 7
LT - Lituania 7
PT - Portogallo 7
BH - Bahrain 6
IL - Israele 6
KE - Kenya 6
MA - Marocco 6
AZ - Azerbaigian 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CR - Costa Rica 4
KZ - Kazakistan 4
MD - Moldavia 4
PE - Perù 4
DK - Danimarca 3
DZ - Algeria 3
LB - Libano 3
MN - Mongolia 3
PS - Palestinian Territory 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
MU - Mauritius 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CU - Cuba 1
GE - Georgia 1
Totale 25.166
Salva come PNG Salva come JPEG
Città #
Singapore 1.479
Southend 1.110
Ashburn 1.094
Chandler 806
Fairfield 763
Hong Kong 555
Ho Chi Minh City 550
Santa Clara 487
San Jose 481
Hanoi 436
Dong Ket 421
Woodbridge 411
Houston 358
Princeton 349
Seattle 333
Wilmington 329
Dublin 293
Ann Arbor 291
Beijing 282
Cambridge 273
Boardman 187
Hefei 177
Lauterbourg 169
Jacksonville 167
Bologna 158
Los Angeles 151
Lomé 139
Abidjan 129
New York 129
Tokyo 128
Berlin 127
Helsinki 126
Nanjing 124
Westminster 114
Padova 104
Milan 103
Sofia 96
Amman 93
Buffalo 82
Da Nang 80
Bern 79
Council Bluffs 79
Frankfurt am Main 77
San Diego 76
Seoul 75
Haiphong 72
Dallas 65
Shenyang 64
Phoenix 55
Turin 55
São Paulo 53
Saint Petersburg 52
Guangzhou 50
Changsha 47
Redondo Beach 45
Hebei 43
Jinan 43
Brussels 42
Nanchang 42
Mülheim 38
Rome 36
Yubileyny 36
London 35
Bremen 34
Henderson 34
Medford 34
Redwood City 34
Shanghai 33
Munich 32
Chicago 31
Washington 31
Falkenstein 29
Orem 29
Tianjin 29
Atlanta 28
Montreal 28
Boston 27
San Francisco 27
Centro 26
Saint Louis 26
Hải Dương 25
Bengaluru 24
Dearborn 23
Olalla 23
Quận Bình Thạnh 23
Redmond 23
Jiaxing 22
Brierley Hill 21
Haikou 21
Toronto 21
Zhengzhou 20
Can Tho 19
Mahé 19
Nuremberg 19
Taizhou 19
Thái Nguyên 19
Warsaw 19
Mumbai 18
Ninh Bình 18
Norwalk 18
Totale 15.869
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 678
Ulcerative Colitis 372
Essential oils as intestinal microbiota regulators in models of mice induced colitis. 321
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 320
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 294
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 275
Adult attachment and early parental experiences in patients with Crohn’s Disease 258
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 255
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 246
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 245
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 244
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 243
Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: Implications in colonic pathophysiology 243
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 237
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 236
Attachment and perceived stress in patients with ulcerative colitis, a case–control study 232
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 232
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study 231
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 227
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 227
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 223
Medical treatment and management of severe ulcerative colitis 221
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 219
Infliximab in the treatment of Crohn's disease 217
Attachment and quality of life in patients with inflammatory bowel disease 215
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 214
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 212
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 211
Attachment and mentalizing abilities in patients with inflammatory bowel disease 211
High-dose probiotics for the treatment of active pouchitis 210
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 210
Influence of steroid treatment's duration in patients with active Crohn's disease 206
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 200
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 199
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 198
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 194
Clinical course of microscopic colitis in a single-center cohort study 193
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 192
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 191
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 190
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 190
Antibiotics and probiotics in treatment of inflammatory bowel disease 188
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 187
Management and treatment of distal ulcerative colitis 187
Oral budesonide in the treatment of chronic refractory pouchitis. 186
Alessitimia e stress percepito in 323 pazienti affetti da IBD 184
Review article: aminosalicylates for distal colitis 182
Management of inflammatory bowel disease: does rifaximin offer any promises 181
Role of conventional therapies in the era of biological treatment in Crohn's disease. 181
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 180
Parental Bonding and Inflammatory Bowel Disease 180
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 178
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 177
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 176
MANAGEMENT OF POUCHITIS 175
The role of Budesonide-MMX in active ulcerative colitis. 174
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 172
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 172
Which therapies are advisable in pouchitis? 170
Antimicrobials in the management of inflammatory bowel disease 170
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 168
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 167
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 165
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 165
Sympathetic hyperactivity in patients with ulcerative colitis. 164
Randomized controlled trials in pouchitis 164
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 164
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 163
Oral beclomethasone dipropionate in chronic refractory pouchitis 162
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 162
Problematic proctitis and distal colitis 162
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 160
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 160
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 160
null 159
Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice 158
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx 155
Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations 155
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 154
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 152
The role of antibiotics and probiotics in pouchitis 151
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 149
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. 145
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 144
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 142
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 142
Probiotic therapy to prevent pouchitis onset 142
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin 141
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 139
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 137
M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis 137
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 136
TREATMENT OF PERIANAL CROHN'S DISEASE WITH COMBINED SURGICAL AND BIOLOGICAL THERAPY 136
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients 136
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials 133
ORAL BECLOMETHASONE DIPROPIONATE IN THE TREATMENT OF CHRONIC REFRACTORY POUCHITIS 129
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 128
Totale 19.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021708 0 0 0 0 0 0 0 0 0 0 0 708
2021/20222.895 307 68 172 138 213 106 65 124 262 228 806 406
2022/20233.471 379 509 198 413 198 294 82 199 666 81 229 223
2023/2024989 69 147 92 77 98 272 46 51 21 61 27 28
2024/20253.291 176 490 291 218 649 158 207 111 41 219 95 636
2025/20268.245 913 626 666 532 903 524 777 249 1.833 700 251 271
Totale 25.752